🔗 Permalink

Inventor profile of:

Brigitte Devaux

City:

Palo Alto, California

Country:

United States

Published Applications:

Last publication date:

2025-10-23

Top Assignees for applications by Brigitte Devaux

The entities that hold a legal rights for patent applications filed by inventor Devaux Brigitte:

BRISTOL-MYERS SQUIBB COMPANY 32 Princeton, NJ United States
PFIZER INC. 14 New York, NY United States
Genentech, Inc. 3 South San Francisco, CA United States
PFIZER INC. 3 ST. LOUIS, MO United States
BRISTOL-MYERS SQUIBB COMPANY 2 MILPITAS, CA United States
CytomX Therapeutics, Inc. 2 South San Francisco, CA United States
THE ROCKEFELLER UNIVERSITY 2 New York, NY United States
Bristol-Myers Squibb Company 1 Priceton, NJ United States
Genetech, Inc. 1 South San Francisco, CA United States

Recent patent applications by Devaux Brigitte

Brigitte Devaux from Palo Alto, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-23

US20250326841A1

Chemistry; metallurgy

ANTIBODIES AGAINST TIM3 AND USES THEREOF

#2 | 2025-06-19

US20250197494A1

Chemistry; metallurgy

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

#3 | 2025-04-10

US20250115664A1

Chemistry; metallurgy

ANTIBODIES AGAINST TIM3 AND USES THEREOF

#4 | 2024-10-10

US20240336695A1

Chemistry; metallurgy

ANTIBODIES TO CD40

#5 | 2024-06-27

US20240209083A1

Chemistry; metallurgy

ANTIBODIES AGAINST TIM3 AND USES THEREOF

#6 | 2024-05-30

US20240174749A1

Chemistry; metallurgy

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

#7 | 2023-11-30

US20230382992A1

Chemistry; metallurgy

Antibodies against TIM3 and uses thereof

#8 | 2022-12-08

US20220390463A1

Physics

TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF

#9 | 2022-10-13

US20220324989A1

Chemistry; metallurgy

Anti-CD40 antibodies and uses thereof

#10 | 2022-03-24

US20220089720A1

Chemistry; metallurgy

Antibodies against TIM3 and uses thereof

#11 | 2022-01-06

US20220002428A1

Chemistry; metallurgy

BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR

#12 | 2021-11-25

US20210363242A1

Chemistry; metallurgy

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

#13 | 2021-10-21

US20210324072A1

Chemistry; metallurgy

Antibodies to TIGIT

#14 | 2021-02-25

US20210054091A1

Chemistry; metallurgy

ANTIBODIES TO CD40

#15 | 2020-10-29

US20200339700A1

Chemistry; metallurgy

Anti-CD40 antibodies and uses thereof

#16 | 2020-06-18

US20200190186A1

Chemistry; metallurgy

Antibodies against TIM3 and uses thereof

#17 | 2020-03-05

US20200071412A1

Chemistry; metallurgy

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

#18 | 2019-10-31

US20190331694A1

Physics

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

#19 | 2019-08-15

US20190248911A1

Chemistry; metallurgy

Nucleic acids encoding an anti-CD40 antibody

#20 | 2019-08-15

US20190248893A1

Chemistry; metallurgy

ANTIBODIES AGAINST TIM3 AND USES THEREOF

#21 | 2019-05-09

US20190135932A1

Chemistry; metallurgy

BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR

#22 | 2019-04-18

US20190112375A1

Chemistry; metallurgy

Antibodies to TIGIT

#23 | 2018-10-18

US20180298097A1

Chemistry; metallurgy

Antibodies against TIM3 and uses thereof

#24 | 2018-05-24

US20180142030A1

Chemistry; metallurgy

ANTIBODIES TO CD40

#25 | 2018-03-01

US20180057600A1

Chemistry; metallurgy

Binding molecules to the human OX40 receptor

#26 | 2018-02-22

US20180052175A1

Physics

TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF

#27 | 2018-01-18

US20180016336A1

Chemistry; metallurgy

Antibodies against TIM3 and uses thereof

#28 | 2016-12-29

US20160376371A1

Chemistry; metallurgy

Antibodies to CD40 with enhanced agonist activity

#29 | 2016-06-23

US20160176963A1

Chemistry; metallurgy

Antibodies to TIGIT

#30 | 2015-08-06

US20150218279A1

Chemistry; metallurgy

Binding molecules to the human OX40 receptor

#31 | 2015-07-23

US20150203574A1

Chemistry; metallurgy

ANTIBODIES TO IL-6 AND THEIR USES

#32 | 2015-05-14

US20150132311A1

Chemistry; metallurgy

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

#33 | 2014-06-05

US20140154268A1

Chemistry; metallurgy

ALPHA5-BETA1 ANTIBODIES AND THEIR USES

#34 | 2013-10-24

US20130280266A1

Chemistry; metallurgy

Antibodies to IL-6 and their uses

#35 | 2012-09-06

US20120225086A1

Chemistry; metallurgy

Binding molecules to the human OX40 receptor

#36 | 2012-08-09

US20120202285A1

Chemistry; metallurgy

Antibodies to IL-6 and their uses

#37 | 2012-02-23

US20120045443A1

Chemistry; metallurgy

Agonist anti-trk-c monoclonal antibodies

#38 | 2012-01-12

US20120009622A1

Chemistry; metallurgy

Alpha5-beta1 antibodies and their uses

#39 | 2011-08-25

US20110206681A1

Chemistry; metallurgy

Binding molecules to the human OX40 receptor

#40 | 2010-12-30

US20100330078A1

Chemistry; metallurgy

Alpha 5-beta 1 antibodies and their uses

#41 | 2010-01-07

US20100003261A1

Chemistry; metallurgy

AGONIST ANTI-TRK-C MONOCLONAL ANTIBODIES

#42 | 2009-12-24

US20090317402A1

Chemistry; metallurgy

Antibodies to IL-6 and their uses

#43 | 2009-08-27

US20090214560A1

Chemistry; metallurgy

Binding molecules to the human OX40 receptor

#44 | 2008-06-10

US10312316

Agonist anti-trk-C monoclonal antibodies

#45 | 2007-02-15

US20070036794A1

Chemistry; metallurgy

Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies

#46 | 2005-02-17

US20050036942A1

Chemistry; metallurgy

Anti-tumor antibody compositions and methods of use

InventorID:

496692 ⎘